Your browser doesn't support javascript.
loading
Computational stabilization of a non-heme iron enzyme enables efficient evolution of new function.
King, Brianne R; Sumida, Kiera H; Caruso, Jessica L; Baker, David; Zalatan, Jesse G.
Afiliação
  • King BR; Department of Chemistry, University of Washington, Seattle, Washington 98195, United States.
  • Sumida KH; Department of Chemistry and Institute for Protein Design, University of Washington, Seattle, Washington 98195, United States.
  • Caruso JL; Department of Chemistry, University of Washington, Seattle, Washington 98195, United States.
  • Baker D; Institute for Protein Design, Department of Biochemistry, and Howard Hughes Medical Institute, University of Washington, Seattle, Washington 98195, United States.
  • Zalatan JG; Department of Chemistry, University of Washington, Seattle, Washington 98195, United States.
bioRxiv ; 2024 Jul 25.
Article em En | MEDLINE | ID: mdl-39091854
ABSTRACT
Directed evolution has emerged as a powerful tool for engineering new biocatalysts. However, introducing new catalytic residues can be destabilizing, and it is generally beneficial to start with a stable enzyme parent. Here we show that the deep learning-based tool ProteinMPNN can be used to redesign Fe(II)/αKG superfamily enzymes for greater stability, solubility, and expression while retaining both native activity and industrially-relevant non-native functions. For the Fe(II)/αKG enzyme tP4H, we performed site-saturation mutagenesis with both the wild-type and stabilized design variant and screened for activity increases in a non-native C-H hydroxylation reaction. We observed substantially larger increases in non-native activity for variants obtained from the stabilized scaffold compared to those from the wild-type enzyme. ProteinMPNN is user-friendly and widely-accessible, and straightforward structural criteria were sufficient to obtain stabilized, catalytically-functional variants of the Fe(II)/αKG enzymes tP4H and GriE. Our work suggests that stabilization by computational sequence redesign could be routinely implemented as a first step in directed evolution campaigns for novel biocatalysts.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article